Evidence map›Paper›PMID 37395979›Full record

ArticleBreast cancer (Tokyo, Japan)2023

Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.

Sumito Saeki, Tsuguo Iwatani, Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, Yusuke Kajimoto, Sayaka Kuba, Fumikata Hara and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Breast cancer (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Sumito SaekiBreast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. sumito.saeki@jfcr.or.jp.ORCID http://orcid.org/0009-0001-8225-923X
Tsuguo IwataniDepartment of Breast Surgery, National Cancer Center Hospital East, Chiba, Japan.ORCID http://orcid.org/0000-0001-7162-1515
Atsuko KitanoDepartment of Medical Oncology, St Luke's International Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8881-3329
Naomi SakuraiCancer Solutions, Inc, Tokyo, Japan.
Yuko TanabeDepartment of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
Chikako YamauchiRadiation Therapy Center, Shiga General Hospital, Moriyama, Japan.ORCID http://orcid.org/0000-0003-1799-8535
Ataru IgarashiDepartment of Pharmaceutical Policy, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6307-6916
Yusuke KajimotoGraduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3681-5757
Sayaka KubaGraduate School of Biomedical Sciences, Department of Surgery, Nagasaki University, Nagasaki, Japan.ORCID http://orcid.org/0000-0002-0225-099X
Fumikata HaraBreast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.ORCID http://orcid.org/0000-0001-8025-3494
Yasuaki SagaraDepartment of Breast and Thyroid Surgical Oncology, Hakuaikai Sagara Hospital, Kagoshima, Japan.ORCID http://orcid.org/0000-0001-5705-1739
Shinji OhnoBreast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.ORCID http://orcid.org/0000-0003-2093-3353
Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37395979
PMCPMC10404164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.